HCP, Inc. (NYSE:HCP) Rating Reiterated by Jefferies Group LLC

HCP, Inc. (NYSE:HCP)‘s stock had its “hold” rating reaffirmed by Jefferies Group LLC in a research note issued to investors on Tuesday. They currently have a $33.00 target price on the real estate investment trust’s stock. Jefferies Group LLC’s target price suggests a potential upside of 3.16% from the stock’s previous close.

A number of other brokerages have also weighed in on HCP. BidaskClub lowered shares of HCP from a “buy” rating to a “hold” rating in a research note on Thursday, June 29th. Zacks Investment Research lowered shares of HCP from a “hold” rating to a “sell” rating in a research note on Tuesday, July 18th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $31.00 target price on shares of HCP in a research note on Friday, July 14th. Goldman Sachs Group, Inc. (The) lowered shares of HCP from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $35.00 to $32.00 in a research note on Monday. Finally, Evercore ISI raised shares of HCP from an “underperform” rating to an “in-line” rating in a research note on Monday, March 27th. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and three have issued a buy rating to the company’s stock. HCP currently has an average rating of “Hold” and an average target price of $33.42.

Shares of HCP (NYSE:HCP) traded down 0.297% during mid-day trading on Tuesday, hitting $31.895. The company had a trading volume of 2,150,379 shares. HCP has a one year low of $27.61 and a one year high of $40.43. The firm’s 50-day moving average price is $32.00 and its 200 day moving average price is $31.28. The company has a market capitalization of $14.95 billion, a P/E ratio of 15.378 and a beta of 0.37.

HCP (NYSE:HCP) last announced its quarterly earnings results on Tuesday, May 2nd. The real estate investment trust reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.03. The company had revenue of $492.16 million during the quarter, compared to analyst estimates of $514.82 million. HCP had a net margin of 41.38% and a return on equity of 12.39%. The firm’s revenue was down 5.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.69 EPS. Analysts predict that HCP will post $1.35 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “HCP, Inc. (NYSE:HCP) Rating Reiterated by Jefferies Group LLC” was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://stocknewstimes.com/2017/07/27/hcp-inc-nysehcp-rating-reiterated-by-jefferies-group-llc.html.

In other news, insider Thomas Klaritch sold 2,651 shares of the stock in a transaction dated Tuesday, June 13th. The shares were sold at an average price of $31.53, for a total transaction of $83,586.03. Following the completion of the transaction, the insider now directly owns 176,830 shares in the company, valued at approximately $5,575,449.90. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 0.22% of the company’s stock.

Several large investors have recently modified their holdings of the stock. Parkside Financial Bank & Trust boosted its stake in shares of HCP by 0.8% in the second quarter. Parkside Financial Bank & Trust now owns 7,194 shares of the real estate investment trust’s stock worth $230,000 after buying an additional 54 shares during the last quarter. Cleararc Capital Inc. boosted its stake in shares of HCP by 0.7% in the first quarter. Cleararc Capital Inc. now owns 11,441 shares of the real estate investment trust’s stock worth $358,000 after buying an additional 85 shares during the last quarter. Peoples Financial Services CORP. boosted its stake in shares of HCP by 4.0% in the second quarter. Peoples Financial Services CORP. now owns 3,250 shares of the real estate investment trust’s stock worth $104,000 after buying an additional 125 shares during the last quarter. Transamerica Financial Advisors Inc. boosted its stake in shares of HCP by 0.9% in the first quarter. Transamerica Financial Advisors Inc. now owns 17,030 shares of the real estate investment trust’s stock worth $533,000 after buying an additional 145 shares during the last quarter. Finally, Atria Investments LLC boosted its stake in shares of HCP by 1.2% in the second quarter. Atria Investments LLC now owns 12,447 shares of the real estate investment trust’s stock worth $398,000 after buying an additional 147 shares during the last quarter. 88.44% of the stock is currently owned by institutional investors.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply